utilizing frontline bevacizumab in metastatic renal cell carcinoma
Published 11 years ago • 219 plays • Length 7:58Download video MP4
Download video MP3
Similar videos
-
7:15
introduction: multidisciplinary frontline treatment of metastatic renal cell carcinoma
-
7:34
frontline sunitinib compared to everolimus in metastatic renal cell carcinoma
-
6:01
metastatic rcc: using frontline ipilimumab/nivolumab
-
8:43
optimizing the upfront treatment of metastatic renal cell carcinoma
-
9:50
choosing frontline therapy for metastatic kidney cancer
-
3:13
pembrolizumab with bevacizumab for treatment of metastatic kidney cancer
-
6:13
frontline decisions in metastatic kidney cancer
-
8:31
second-line angiogenesis inhibition in metastatic renal cell carcinoma
-
3:57
agile trial: frontline axitinib versus sorafenib in metastatic renal cell carcinoma
-
3:36
first-line treatment of poor-risk metastatic renal cell carcinoma
-
27:47
what is the best front line treatment for metastatic clear cell rcc in 2018?
-
4:38
determining progression in metastatic renal cell carcinoma
-
7:05
upfront immunotherapy for metastatic kidney cancer
-
8:48
evaluating frontline systemic therapy for metastatic rcc
-
10:39
pisces trial and patient treatment preference in metastatic renal cell carcinoma
-
8:50
comparison of frontline renal cell carcinoma treatment options
-
6:57
newly diagnosed metastatic rcc: frontline therapy
-
4:49
frontline tki strategies in kidney cancer
-
5:09
comparz trial and alternate sunitinib dosing schedule in metastatic renal cell carcinoma